Completed NA INTERVENTIONAL 2-arm NCT04510337

Does Adding Magnesium Sulphate to Low Dose Rocuronium Affects Depth of Blockade

Does Adding Magnesium Sulphate to Low Dose Rocuronium Affects the Depth of Blockade in Cancer Patients Undergoing Direct Laryngoscope Surgical Procedures

Sponsor: National Cancer Institute, Egypt

Conditions Anesthesia

Interventions Magnesium sulfate standard rocuronium dose

Updated 8 times since 2020 Last updated: Mar 4, 2021 Started: Apr 2, 2018 Primary completion: Feb 20, 2021 Completion: Feb 20, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04510337, this NA trial focuses on Anesthesia and remains completed. Sponsored by National Cancer Institute, Egypt, it has been updated 8 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2021 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Mar 2021 — Apr 2021 [monthly]

Recruiting NA
Feb 2021 — Mar 2021 [monthly]

Recruiting NA

▶ Show 3 earlier versions

Jan 2021 — Feb 2021 [monthly]

Recruiting NA

Status: Completed → Recruiting
Oct 2020 — Jan 2021 [monthly]

Completed NA
Sep 2020 — Oct 2020 [monthly]

Completed NA

First recorded

Apr 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute, Egypt

Data source: National Cancer Institute, Egypt

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt